Human acellular vessel

Unassigned

New Medicines

Vascular access for haemodialysis in end-stage renal disease

Information

Advanced therapy medicinal product (ATMP)
Humacyte
Humacyte

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

A bio-engineered vascular tube, utilising human vascular cells to form a mechanically strong, engineered tube similar to native blood vessels
In England, each year about 5,800 people start treatment for kidney failure and about four in 10 are treated with haemodialysis while one in 10 is treated with peritoneal dialysis. Around 30,000 patients are on dialysis [1].
Vascular access for haemodialysis in end-stage renal disease
Implantation

Evidence based evaluations